Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL8984045 | 0.93 | SLC18A3 (0.70) | SIGMAR1SLC18A3 | |
| SCHEMBL8984066 | 0.86 | SIGMAR1 (0.73) | SIGMAR1SLC18A3 | |
| Hydrochloric Acid SCHEMBL8984037 | 0.80 | SIGMAR1 (0.80) | SIGMAR1SLC18A3 | |
| Hydrochloric Acid SCHEMBL8984081 | 0.77 | SLC18A3 (0.98) | SIGMAR1SLC18A3 | |
| Hydrochloric Acid SCHEMBL8984084 | 0.77 | SLC18A3 (0.48) | SIGMAR1SLC18A3 | |
| Hydrochloric Acid SCHEMBL8984040 | 0.77 | SIGMAR1 (0.85) | SIGMAR1SLC18A3 | |
| Oxalic Acid SCHEMBL9153295 | 0.73 | SLC18A3 (0.91) | SIGMAR1SLC18A3 | |
| Hydrochloric Acid SCHEMBL8984057 | 0.71 | SIGMAR1 (0.63) | SIGMAR1SLC18A3 | |
| Hydrochloric Acid SCHEMBL8984098 | 0.71 | SIGMAR1 (0.97) | SIGMAR1SLC18A3 | |
| SCHEMBL11701139 | 0.68 | SIGMAR1 (0.57) | SIGMAR1SLC18A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5554752-A | SPIRO FUSED PIPERIDINES CAPABLE OF BINDING TO A VESAMICOL RECEPTOR AND HAVING ANTICHOLINERGIC PROPERTIES | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1996-09-10 | — | — | US | disclosed |
| US-5457207-A | Anticholinergic agents | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1995-10-10 | — | — | US | disclosed |
| WO-1995009631-A1 | SPIROVESAMICOLS | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1995-04-13 | — | — | WO | disclosed |